AzTrials
AzTrials

the Health Status of the Oldest OldNCT04553874

Health Status of the Oldest-old Population

An observational study of the Health Status of the Oldest Old, run by Peking University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to investigate the health status of the oldest-old population and to explore the key factors associated with their quality of life The study will select all the elderly aged 85 years and above from Lanqiying Community, Qinghuayuan Street, Haidian District, Beijing, and enroll them after informed… Read more about this study

Who is it for?
Ages 80 years and older
Conditions the study is for
the Health Status of the Oldest Old
How many people
800 participants
Where
1 siteChina
Study dates
1 Dec 2020to 30 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 80 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: All the people aged 80 years and above in the target community in Beijing will be enrolled, and people who were hospitalized for long period (6 months or more) or at the end of their lives were excluded.

Who may be able to join

  • All the people aged 80 years and above in the target community in Beijing

Who cannot join

  • People who were hospitalized for long period (6 months or more) or at the end of their lives were excluded.

Trial locations and contacts

1 site in 1 country.

chun zhang, doctor contact

8618601031059

zhangc1@yahoo.com

cancan xue, doctor contact

8613051555260

xuecancan1992@163.com

China1 site
  • Peking University Third Hosipital

    Beijing, Beijing Municipality, 100191

Other trials in China

About this study

Official title: Health Status of the Oldest-old Population: a Population-based, Cohort Study

This study aims to investigate the health status of the oldest-old population and to explore the key factors associated with their quality of life The study will select all the elderly aged 85 years and above from Lanqiying Community, Qinghuayuan Street, Haidian District, Beijing, and enroll them after informed consent. Demographic, sociological, economic, physiological information and disease-related records will be collected through questionnaire interviews, scales, and examinations.

After the first survey, the participants will be followed for 2 years to collect information about deaths or major health events. The baseline survey will be re-conducted two years later.

Read the detailed description

This study is a population-based cohort study. Oldest-old people (aged 80 and over) will be enrolled.

Data collection Social economics information include: name, gender, age, nationality, marital status, personal habits, occupation, level of education, family living situation, monthly income, way to go to a doctor and medical payment, etc The health status and disease will be obtained by review the medical records as well as the narration of the subjects and their family members. We will focus on diseases with high disability mortality, high social burden. Multiple indicators or abilities will be evaluated through the scale, including life or acting ability, nutritional status, cognitive ability, psychological status, social support, quality of life self-assessment, etc., so as to comprehensively understand the comprehensive information of the participants.

Basic physical examination and special clinical examination will be performed to obtain multiple objective indicators reflecting the subject's physical function The basic health examination includes; Blood pressure, respiration, heart rate, pulse; Height, weight, waist circumference, hip circumference, arm circumference, calf circumference, grip strength, vital capacity, tooth condition, hearing condition, visual acuity, ECG, etc.

Special examinations include the blood, urine, and stool specimens. Imageological examination like MRI, fundus photography, and optical coherence tomography will also be conducted.

Keywords
oldest-old; epidemiology; population-based; cohort

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Other

    observational study without intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Death

    The incidence of death during the study period

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2020
  2. Study start1 Dec 2020 (estimated)
  3. Primary completion30 Jun 2022 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04553874
Sponsor's protocol ID
IRB00006761-M2020021
Status last verified
Sep 2020
First submitted
12 Sep 2020
Last updated
28 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of the Health Status of the Oldest Old, run by Peking University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact chun zhang, doctor (8618601031059, zhangc1@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Death (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in